Next Article in Journal
Role of Anti-Cancer Peptides as Immunomodulatory Agents: Potential and Design Strategy
Next Article in Special Issue
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials
Previous Article in Journal
Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with N-Dimethylnitrosamine-Induced Liver Cirrhosis
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(12), 2685; https://doi.org/10.3390/pharmaceutics14122685
Action Date Notes Link
article xml file uploaded 1 December 2022 10:32 CET Original file -
article xml uploaded. 1 December 2022 10:32 CET Update https://www.mdpi.com/1999-4923/14/12/2685/xml
article pdf uploaded. 1 December 2022 10:32 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2685/pdf
article supplementary file uploaded. 1 December 2022 10:32 CET - https://www.mdpi.com/1999-4923/14/12/2685#supplementary
article html file updated 1 December 2022 10:35 CET Original file -
article html file updated 1 March 2023 02:00 CET Update -
article html file updated 4 March 2023 00:28 CET Update https://www.mdpi.com/1999-4923/14/12/2685/html
Back to TopTop